Detromethorphan Polistirex


Perrigo Announces FDA Approval Of Generic Delsym

Perrigo Co. (Nasdaq: PRGO) announced that the United States Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser’s Delsym suspension.

WWJ Newsradio 950–05/31/2012